| Full-length and N-terminally truncated recombinant interleukin-38 variants are similarly inefficient in antagonizing interleukin-36 and interleukin-1 receptors | Cell communication and signaling |  | | 2025 | 107 | 72 |
|
| Interleukin-38 overexpression in keratinocytes limits desquamation but does not affect the global severity of imiquimod-induced skin inflammation in mice | Frontiers in immunology | | | 2024 | 144 | 60 |
|
| Oxidation-sensitive cysteines drive IL-38 amyloid formation | Cell reports | | | 2024 | 132 | 53 |
|
| GSDMD is associated with survival in human breast cancer but does not impact anti-tumor immunity in a mouse breast cancer model | Frontiers in immunology | | | 2024 | 197 | 72 |
|
| Cell Intrinsic IL-38 Affects B Cell Differentiation and Antibody Production | International journal of molecular sciences | | | 2023 | 129 | 204 |
|
| Multifaceted roles of IL-38 in inflammation and cancer | Cytokine | | | 2022 | 269 | 303 |
|
| Inhibition of IL-1β release from macrophages targeted with necrosulfonamide-loaded porous nanoparticles | Journal of controlled release | | | 2022 | 394 | 416 |
|
